SO-5 Futibatinib in patients with FGFR2-rearranged intrahepatic cholangiocarcinoma: Responder analyses of efficacy and safety from the phase 2 FOENIX-CCA2 study

Annals of Oncology(2023)

引用 0|浏览2
暂无评分
关键词
intrahepatic cholangiocarcinoma,foenix-cca
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要